Link Information - Click to View
U.K. Approves Europe's First Embryonic Stem Cell Clinical Trial
A U.S.-based company has received permission to start Europe's first clinical trial involving human embryonic stem (hES) cells. Advanced Cell Technology (ACT), based in Marlborough, Massachusetts, received approval today from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to begin a trial that will treat 12 patients with Stargardt's macular dystrophy.
Source: Science
Posted on:
Friday, Sep 23, 2011, 7:55am
Views: 1121